home / stock / ctmx / ctmx articles

CTMX Articles, CytomX Therapeutics Inc. - From 03/12/24

Stock Information
Company Name: CytomX Therapeutics Inc.
Stock Symbol: CTMX
Market: NASDAQ
Website: cytomx.com
Menu
CTMX CTMX Quote CTMX Short CTMX News CTMX Articles CTMX Message Board
Get CTMX Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fisc...
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update | Benzinga

- CX-904 (EGFRxCD3 T-cell engager) initial Phase 1a dose escalation data in solid tumors anticipated in the 2nd half of 2024 - - CX-2051 (EpCAM AD...

CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference | Benzinga

SOUTH SAN FRANCISCO, Calif., Jan. 12, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of conditionally a...

CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

SOUTH SAN FRANCISCO, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of conditionally a...
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update | Benzinga

- CX-904 (EGFRxCD3 T-cell engager) initial Phase 1 dose escalation data anticipated in the first half of 2024 - - CX-2051 (EpCAM-directed ADC) co...

CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting | Benzinga

- IND filing for CX-801 anticipated by the end of 2023 - SOUTH SAN FRANCISCO, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc...

CytomX Therapeutics to Present at Upcoming September Investor Conferences | Benzinga

SOUTH SAN FRANCISCO, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of conditionally ...
Previous 10 Next 10